Rodin XL Tablet 400 mg (Unmodified Etodolac)

Adult dose

Before using etodolac extended-release tablets, carefully consider the potential benefits and risks of the extended-release tablets and other treatment options. After observing the response to initial treatment with this medicine, adjust the dose and regimen according to each individual patient. Adults: The recommended starting dose is 400 ～ 800 mg of etodolac orally once daily. Set the lowest effective dose according to each individual patient's condition. For long-term use, 600 mg of etodolac daily may be sufficient. The therapeutic effect of this medicine appears within 1 week, or within 2 weeks in most cases.

This medication may pose a risk of gastrointestinal bleeding if taken by individuals who regularly consume more than three drinks a day; please consult a doctor or pharmacist before use. This medication may affect the cardiovascular system, potentially increasing the risk of serious cardiovascular events such as myocardial infarction or stroke. Caution is especially needed for those with existing cardiovascular diseases or risk factors. Serious issues such as gastrointestinal bleeding, ulcers, or perforations may occur with prolonged use or in the elderly, so special care should be taken. Individuals with a history of peptic ulcers or bleeding, those allergic to the components of this medicine, those who have had hypersensitivity reactions to aspirin, individuals with severe liver, kidney, or cardiac dysfunction, and women in late pregnancy should not take this medication. Those with impaired renal or liver function, heart failure, hypertension, asthma patients, those with a history of blood disorders, and the elderly should take this medication with caution and closely monitor their condition while taking it. There are various possible side effects including severe allergic reactions, skin reactions, blood disorders, and liver or kidney dysfunction, so if symptoms occur, discontinue use immediately and seek medical attention. Before taking, check for possible interactions with this medication and others, especially when taken with blood pressure medications, diuretics, anticoagulants, or cancer therapies. This medication should not be taken during pregnancy, particularly in late stages, as it may pose risks to the fetus, and nursing mothers should decide on use after consultation with a doctor. Safety for use in children has not been established, so it is advisable to avoid using it in this population. Older adults may have decreased kidney function, potentially leading to drug accumulation in the body, requiring dose adjustments and close monitoring for side effects. Overdose may result in gastrointestinal bleeding, drowsiness, dizziness, vomiting, and there is no specific antidote, so immediate medical treatment is necessary. This medication should be kept out of reach of children, and transferring to other containers should be avoided to prevent quality degradation or accident risks.

Shock, anaphylactic symptoms, abdominal pain, vomiting, hematemesis, melena, gastrointestinal bleeding, Stevens-Johnson syndrome, toxic epidermal necrolysis, pancytopenia, hemolytic anemia, agranulocytosis, thrombocytopenia, acute renal failure, worsening of chronic renal failure, liver dysfunction, jaundice, congestive heart failure, eosinophilic pneumonia, interstitial pneumonia, nausea, diarrhea, upper abdominal pain, loss of appetite, hepatitis, belching, elevated liver enzymes, heartburn, indigestion, bloating, abdominal pain, gastrointestinal cramps, abdominal gas retention, constipation, gastritis, bloody stool, thirst, dry mouth, ulcerative stomatitis, melanosis, esophagitis with stricture or pyloric muscle spasm, colitis, ischemic colitis, ulcerative colitis, colonic ulcer, pseudomembranous colitis, pancreatitis, headache, dizziness, drowsiness, insomnia, nervousness, anxiety, depression, weakness, lethargy, somnolence, paralysis, coma, sensory disturbance, confusion, itching, rash, angioedema, sweating, urticaria, vesicular eruption, subcutaneous vasculitis with purpura, hyperpigmentation, erythema multiforme, alopecia, skin desquamation, papular rash, photosensitivity reaction, nipple necrosis, chills, fever, fatigue, malaise, allergic reaction, infectious disease, dysuria, increased urinary frequency, renal insufficiency, renal dysfunction, renal papillary necrosis, cystitis, hematuria, leukorrhea, kidney stones, interstitial nephritis, irregular uterine bleeding, blurred vision, lifespan, tinnitus, photophobia, transient visual disturbance, conjunctivitis, hearing loss, taste disturbances, hypotension, hypertension, flushing, tachycardia, palpitations, syncope, vasculitis, petechiae, anemia, thrombocytopenia, prolonged bleeding time, agranulocytosis, hemolytic anemia, leukopenia, neutropenia, pancytopenia, arrhythmia, myocardial infarction, fluid retention, cerebrovascular accident, asthma, bronchitis, dyspnea, pharyngitis, rhinitis, sinusitis, venous thrombophlebitis, edema, elevated serum creatinine, weight change, hyperglycemia, drowsiness, dizziness, respiratory depression, coma

This medication should be stored in a tightly sealed container that blocks light, and the storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Storing in this manner helps maintain the medication's effectiveness and prevents degradation.

Appearance

Bright red oblong film-coated tablet

Package unit

40 tablets (10 tablets/PTPX4), 500 tablets/bottle